List of Benchling Connect Customers
San Francisco, 94107, CA,
United States
Since 2010, our global team of researchers has been studying Benchling Connect customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Benchling Connect for Laboratory Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Benchling Connect for Laboratory Management include: Amgen, a United States based Life Sciences organisation with 28000 employees and revenues of $33.42 billion, Maple Leaf Foods, a Denmark based Life Sciences organisation with 10452 employees and revenues of $2.66 billion, National Resilience, Inc., a United States based Professional Services organisation with 2000 employees and revenues of $500.0 million, Adaptive Biotechnologies, a United States based Life Sciences organisation with 790 employees and revenues of $185.0 million and many others.
Contact us if you need a completed and verified list of companies using Benchling Connect, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Benchling Connect customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight | Insight Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Adaptive Biotechnologies | Life Sciences | 790 | $185M | United States | Benchling | Benchling Connect | Laboratory Management | 2024 | n/a | In 2024 Adaptive Biotechnologies deployed Benchling Connect to modernize molecular research operations, aligning its experimental workflows with a Laboratory Management platform. Adaptive Biotechnologies implemented Benchling Connect to address manual, error prone processes in its NGS and PCR workflows used by the molecular research team in Seattle, unifying data and instrument control under a single application. The deployment configured Benchling Connect to automate sample and reagent registration, tracking, and retrieval, and to orchestrate bidirectional data flows between digital workflows and lab hardware. Benchling Connect was integrated with Benchling Registry and Results schemas so instrument outputs are captured in normalized formats, and the system auto generates metadata CSVs required for downstream omics pipelines. Integrations included direct links to Hamilton liquid handlers and other lab instruments, enabling command and data exchange without manual CSV construction or copy and paste steps. Operational coverage focused on lab operations and molecular research, moving scientist tasks from manual file handling to instrument driven workflows, and ensuring instrument output is pre formatted for NGS analysis. Governance and workflow changes centralized data ownership inside Benchling Connect and reduced the need for weekly manual audits by enforcing structured Registry and Results records. Outcomes reported by Adaptive include weekly file handling errors dropping to nearly zero, a reduction of over 20 hours of manual rework per month, faster resolution of data issues that previously took hours, and NGS workflow throughput increasing by nearly 1.5x, while delivering fully traceable datasets that are easier to share across teams. | |
 |
Amgen | Life Sciences | 28000 | $33.4B | United States | Benchling | Benchling Connect | Laboratory Management | 2023 | n/a | In 2023 Amgen initiated a phased enterprise rollout of Benchling for R&D informatics and adopted Benchling Connect capabilities as part of that program. The implementation centered on Benchling Connect within the Laboratory Management domain, leveraging Benchling's open-source instrument data converters which Amgen publicly endorsed. That public endorsement positions Benchling Connect's instrument-conversion functionality as a core element for lab informatics workflows. Operational scope focused on R&D informatics, with configuration workstreams directed at instrument data ingestion, conversion, and automation of downstream data pipelines to reduce manual data-pipeline maintenance and accelerate lab automation. Governance for the rollout was phased, indicating staged onboarding and workflow restructuring to integrate instrument-conversion capabilities into existing Laboratory Management processes. The linkage of Amgen leadership quotes to Benchling's open-source instrument data converter initiative supports an analyst inference that Benchling Connect was used to operationalize instrument-level data flows within Amgen's R&D informatics environment. | |
 |
Maple Leaf Foods | Life Sciences | 10452 | $2.7B | Denmark | Benchling | Benchling Connect | Laboratory Management | 2024 | n/a | In 2024 Novonesis implemented Benchling Connect as part of a broader Benchling R&D Cloud deployment to modernize R&D data capture, collaboration, and to create AI ready data foundations across global teams. Benchling Connect was adopted within a Laboratory Management context to support scientific record keeping, standardized workflows, and cross team analysis for R&D functions. The implementation centered on laboratory management capabilities common to the category, with inferred module level usage of Benchling Connect including experiment and electronic lab notebook records, sample and inventory tracking, protocol management, and structured assay data capture. Configuration emphasized standardized metadata schemas and template based workflows to enforce consistent experiment capture across discovery and development pipelines. Deployment used the Benchling R&D Cloud as the delivery model, enabling centralized cloud hosted data storage and API accessible experiment records. Instrument and data management integrations are treated as an informed inference, aligned with the Benchling Connect scope, to ingest instrument outputs and pipeline data into unified experiment records and to establish the AI ready data foundation described in the public announcement. Operational coverage targeted approximately 1,500 scientists across Novonesis global R&D teams, impacting research, analytical, and development functions by centralizing experiment data and collaboration artifacts. Governance workstreams focused on standard operating procedures for data capture, metadata governance, and workflow standardization to accelerate analysis and cross team collaboration as stated in the rollout description. | |
 |
|
Professional Services | 2000 | $500M | United States | Benchling | Benchling Connect | Laboratory Management | 2023 | n/a |
|
|
Buyer Intent: Companies Evaluating Benchling Connect
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||